Get the Stockscreener App
53.43
10.98%
-7.23
Agilon Health Inc stock is traded at $53.43, with a volume of 611.89K.
It is down -10.98% in the last 24 hours and up +192.37% over the past month.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
See More
Previous Close:
$60.66
Open:
$61.39
24h Volume:
611.89K
Relative Volume:
1.58
Market Cap:
$888.41M
Revenue:
$5.93B
Net Income/Loss:
$-405.35M
P/E Ratio:
-2.1946
EPS:
-24.3461
Net Cash Flow:
$-148.87M
1W Performance:
+82.56%
1M Performance:
+192.37%
6M Performance:
+223.75%
1Y Performance:
-32.92%
1-Day Range:
$51.60
$61.39
1-Week Range:
$25.39
$63.87
52-Week Range:
$7.48
$82.00
Agilon Health Inc Stock (AGL) Company Profile
Name
Agilon Health Inc
Sector
Industry
Phone
562-256-3800
Address
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
53.25 | 1.01B | 5.93B | -405.35M | -148.87M | -24.35 |
HCA
Hca Healthcare Inc
|
433.19 | 95.17B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
189.88 | 16.72B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
195.67 | 12.60B | 13.64B | 1.05B | 1.31B | 9.555 |
FMS
Fresenius Medical Care Ag Adr
|
21.77 | 11.63B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
107.09 | 10.63B | 6.07B | 793.80M | 464.40M | 5.9914 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Aug-06-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-25 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-10-25 | Upgrade | Citigroup | Sell → Neutral |
| Jan-10-25 | Initiated | Needham | Hold |
| Dec-16-24 | Initiated | Macquarie | Neutral |
| Dec-11-24 | Initiated | Bernstein | Mkt Perform |
| Nov-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-30-24 | Downgrade | Citigroup | Neutral → Sell |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Apr-22-24 | Initiated | Citigroup | Neutral |
| Mar-06-24 | Initiated | Barclays | Underweight |
| Feb-26-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-26-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Stifel | Buy → Hold |
| Jan-08-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-05-24 | Downgrade | Truist | Buy → Hold |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-21-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-23 | Initiated | The Benchmark Company | Buy |
| Jun-13-23 | Initiated | Evercore ISI | In-line |
| Dec-09-22 | Initiated | Stifel | Buy |
| Sep-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Sep-12-22 | Initiated | Goldman | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| Jun-24-22 | Initiated | BTIG Research | Neutral |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Oct-20-21 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| May-11-21 | Initiated | William Blair | Outperform |
| May-10-21 | Initiated | BofA Securities | Buy |
| May-10-21 | Initiated | Deutsche Bank | Buy |
| May-10-21 | Initiated | Goldman | Buy |
| May-10-21 | Initiated | JP Morgan | Overweight |
| May-10-21 | Initiated | Truist | Buy |
| May-10-21 | Initiated | Wells Fargo | Overweight |
| May-10-21 | Initiated | Wolfe Research | Outperform |
View All
Agilon Health Inc Stock (AGL) Latest News
What's Going On With Agilon Health Stock Friday? - Benzinga
Agilon Health soars after surpassing analyst Q1 expectations - Mugglehead Investment Magazine
Agilon Health (AGL) Swings To Q1 Profit Challenging Longstanding Loss-Making Narrative - simplywall.st
Agilon Health Stock More Than Doubles After Q1 Beat. The Turnaround Test Starts Now - TechStock²
Truist Financial Maintains Agilon Health(AGL.US) With Hold Rating - Moomoo
AGL Stock Rips Higher After Blowout Q1 Earnings Beat - timothysykes.com
Agilon Health is up 115% after earnings. Why the stock is having its best day ever. - MSN
Why Is AGL Stock Rising Today? - Stocktwits
Dow Dips 350 Points; US Foods Posts Downbeat Earnings - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Agilon Health Is Up 115% After Earnings. Why the Stock Is Having Its Best Day Ever. - Barron's
AGL Stock Soars As Earnings Beat Fuels Growth Story - StocksToTrade
Agilon Health Operational Initiatives Begin Showing Results - Benzinga
Agilon Health upgraded to Buy from Hold at Jefferies - TipRanks
AGL Stock Jumps As Earnings Beat Fuels Growth Story - timothysykes.com
Agilon Health upgraded to Buy from Hold at Deutsche Bank - TipRanks
US Stocks Mixed; Dow Falls Over 100 Points - Benzinga
Why is agilon health stock surging today? By Investing.com - Investing.com Australia
Agilon Health Up Nearly 94%, on Track for Record Percent Increase - Moomoo
Why is agilon health stock surging today? - Investing.com
Bernstein SocGen reiterates agilon health stock rating on strong quarter By Investing.com - Investing.com South Africa
Agilon Health, Inc. (NYSE:AGL) Q1 2026 Earnings Call Transcript - Insider Monkey
Jefferies Upgrades agilon health to Buy From Hold, Adjusts Price Target to $48 From $27.50 - marketscreener.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Prologis To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Agilon Health | 10-Q: Q1 2026 Earnings Report - Moomoo
Agilon Health forecasts $5.7B 2026 revenue as it raises outlook after Q1 outperformance - MSN
This Fortinet Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Agilon Health Q1 Earnings Call Highlights - Yahoo Finance
Bernstein SocGen reiterates agilon health stock rating on strong quarter - Investing.com
Agilon Health Q1 2026 Earnings Call Transcript - MarketBeat
Deutsche Bank upgrades agilon health stock rating on raised guidance By Investing.com - Investing.com Australia
Jefferies upgrades agilon health stock rating on rate visibility By Investing.com - Investing.com Australia
Deutsche Bank upgrades agilon health stock rating on raised guidance - Investing.com
Jefferies upgrades agilon health stock rating on rate visibility - Investing.com
Jefferies Upgrades agilon health Inc (AGL) to Buy - StreetInsider
agilon health (AGL) Q1 2026 Earnings Transcript - AOL.com
Agilon Health Inc. (AGL) Tops Q1 EPS by 288c ; Offers Guidance - StreetInsider
William Blair Initiates Agilon Health(AGL.US) With Hold Rating - Moomoo
Agilon Health | 8-K: agilon health Reports First Quarter 2026 Results - Moomoo
Agilon Health Earnings Call: Profits Up, Growth Cautious - TipRanks
Earnings call transcript: Agilon Health Q1 2026 shows strategic gains By Investing.com - Investing.com Australia
Agilon Health (AGL) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
agilon health (NYSE:AGL) Reports Strong Q1 CY2026, Stock Jumps 27.9% - StockStory
Agilon (AGL) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Agilon Health Inc (NYSE:AGL) Swings to Profit, Crushes Q1 Estimates, Sends Shares Soaring - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Agilon: Q1 Earnings Snapshot - marketscreener.com
[10-Q] agilon health, inc. Quarterly Earnings Report - Stock Titan
Agilon health, inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Profit surges as agilon health (NYSE: AGL) raises 2026 revenue and EBITDA targets - Stock Titan
Agilon Health Inc Stock (AGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):